FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine - Kaiser Health News

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine  Kaiser Health NewsIn March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say ...